In addition, the combination of mTOR inhibitors, such as dactolisib198, or INK128 (ref. 199), with ALK inhibitors or other conventional chemotherapeutics has shown the ability of the treatment to overcome drug resistance and to prevent NB tumor growth. Here, ALK is linked to neuroblastoma.